Epidermal growth factor receptor (EGFR) signaling in the tissue around oral cancers both increases nerve sensitivity and ...

Opioids remain a staple in pain management for cancer, but there is little guidance around how to treat patients who have a history of opioid misuse. Recently, a group of palliative and addiction ...

Please provide your email address to receive an email when new articles are posted on . Opioids prescribing declined from 2016 to 2020 for patients with cancer in Connecticut who did not report ...

Please provide your email address to receive an email when new articles are posted on . Three measures of opioid prescribing for people with cancer declined significantly after cannabis dispensaries ...

Rutgers has granted Tonix Pharmaceutical exclusive worldwide rights to develop and commercialize a novel class of compounds ...

As physicians and policymakers search for ways to deal with excess pills fueling the opioid epidemic, cancer physicians fear potential shortages in injectable opioids needed to treat critically ill ...

A national claims analysis found that opening medical or recreational cannabis dispensaries was associated with fewer opioid prescriptions and shorter opioid supplies among commercially insured adults ...

InhaleRx Limited (AU:IRX) has released an update. InhaleRx Limited has received ethics approval to commence Phase 2 clinical trials for IRX-211, an innovative non-opioid treatment for breakthrough ...

Over 200 adverse events were reported with a single injection of resiniferatoxin in 19 patients with refractory cancer pain. At least one adverse event occurred in all patients. Resiniferatoxin was ...

A new study finds that an increasing number of surgeries — and the painkillers that follow — could derail recovery for those who once misused opioids.